Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- benznidazole
- indium oxyquinoline in-111
Interactions between your drugs
indium oxyquinoline In-111 benznidazole
Applies to: indium oxyquinoline in-111, benznidazole
Treatment with benznidazole can interfere with indium oxyquinoline In-111 test results. Let your doctor know you are on benznidazole if you are scheduled for a indium oxyquinoline In-111 test. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
benznidazole food/lifestyle
Applies to: benznidazole
Consumption of alcoholic beverages or products containing alcohol or propylene glycol during treatment with benznidazole is not recommended. Doing so may occasionally trigger a reaction in some patients similar to the disulfiram reaction, which includes unpleasant effects such as flushing, throbbing in head and neck, throbbing headache, difficulty breathing, nausea, vomiting, sweating, thirst, chest pain, rapid heartbeat, palpitation, low blood pressure, dizziness, lightheadedness, blurred vision, and confusion. Rarely, more severe reactions may include abnormal heart rhythm, heart attack, heart failure, unconsciousness, convulsions, and even death. Patients treated with benznidazole should continue to avoid using any products containing alcohol or propylene glycol for at least 3 days until after completion of therapy. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Nebupent
Nebupent is used for leishmaniasis, pneumocystis pneumonia, pneumocystis pneumonia prophylaxis ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Lampit
Lampit (nifurtimox) is used for the treatment of Chagas disease in children. Includes Lampit side ...
Pentam 300
Pentam 300 is used for leishmaniasis, pneumocystis pneumonia, pneumocystis pneumonia prophylaxis ...
Pentamidine
Pentamidine is used for leishmaniasis, pneumocystis pneumonia, pneumocystis pneumonia prophylaxis ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.